Morgan Stanley Bitcoin ETF reaches $83.6M, market reaction muted
Morgan Stanley's Bitcoin ETF has accumulated $83.6 million in holdings, signaling real institutional investment in the crypto market. Despite this significant inflow, the immediate market reaction has been muted, with Bitcoin's price expectations for April 15 remaining flat. However, long-term optimism is evident, as indicated by a 36.5% probability of Bitcoin reaching $100,000 by year-end.
BofA raises CenterPoint Energy stock price target to $44 on valuation
BofA Securities has increased its price target for CenterPoint Energy (NYSE:CNP) stock to $44 from $42, while maintaining a Neutral rating, adjusting its valuation to 2028 using peer group multiples. The utility company's stock is currently trading near its 52-week high, and BofA analysts have updated EPS estimates, reflecting the company's target growth rate. CenterPoint Energy has also been active in financing, issuing senior secured system restoration bonds and convertible senior notes, and continues its consistent dividend payments.
Leidos Forms Joint Venture with Altaris and Analogic
Leidos Holdings is forming a joint venture with Altaris affiliates and Analogic, combining Leidos’ Security Enterprise Solutions and Industrial Automation operations with Analogic. Leidos will hold a 41.5% stake in the new company, which will operate under the Analogic brand and focus on accelerating AI-native and 3D imaging solutions for security screening. This move allows Leidos to redirect capital toward its core growth priorities under the NorthStar 2030 strategy.
Labcorp's new 10-minute fentanyl test gives ER teams faster answers
Labcorp has launched a new FDA-cleared rapid fentanyl urine test that delivers results in just 10 minutes. This test detects norfentanyl, a fentanyl metabolite, offering a detection window of up to 48 hours, which assists healthcare providers in emergency departments and clinics with quick decision-making for suspected fentanyl exposure. The test is intended for preliminary screening by qualified professionals in CLIA-certified settings and results should be confirmed by laboratory methods.
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
Labcorp has launched the Labcorp Fentanyl Urine Visual Test, the first FDA-cleared rapid fentanyl test manufactured in the U.S. This test provides results in 10 minutes, assisting healthcare providers in emergency departments, hospitals, and clinics with quick and actionable information regarding suspected fentanyl exposure. The test detects norfentanyl, a fentanyl metabolite, offering a longer detection window and is available through Labcorp Point of Care.
Moderna schedules May 1 webcast for first-quarter 2026 results
Moderna (NASDAQ: MRNA) announced it will report its first-quarter 2026 financial results on Friday, May 1, 2026, with a live conference call and webcast at 8:00 a.m. ET. The company will also provide a corporate update during the call, with an archived webcast available two hours later for one year. This announcement follows a historical pattern for scheduling earnings calls, which has typically resulted in limited short-term stock price impact.
Coca-Cola bottling partner Kandhari Global names Aditya Vasishtha as VP
Kandhari Global Beverages Private Limited (KGBPL), a key bottling partner of The Coca-Cola Company in India, has appointed Aditya Vasishtha as Vice President of Government Affairs & Strategic Partnerships. Vasishtha will be responsible for government relations, strategic partnerships, sustainability, and communications. He previously worked at Coca-Cola India and brings experience in business strategy and public policy to his new role.
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Moderna, Inc. (NASDAQ:MRNA) announced it will report its first quarter 2026 financial results on Friday, May 1, 2026. The biotech company will host a live conference call and webcast at 8:00 a.m. ET to discuss the results and provide a corporate update. The webcast will be available on Moderna's investor relations website, and an archived version will be accessible for one year.
JPMorgan Adjusts Price Target on Duke Energy to $139 From $138, Maintains Neutral Rating
JPMorgan has increased its price target for Duke Energy (DUK) to $139 from $138, while reiterating a Neutral rating on the stock. This adjustment comes amidst other analyst actions on Duke Energy, including BMO Capital and Barclays also modifying their price targets. The article also touches upon the company's profile and recent news, including regulatory approvals for new natural gas generation facilities.
Caterpillar Names Kyle Epley as New CFO in Leadership Transition
Caterpillar has announced that Kyle Epley will succeed Andrew Bonfield as Chief Financial Officer on May 1, 2026. Bonfield, who is retiring in October 2026, oversaw a period of record financial performance for the company, including $67.6 billion in sales and revenues in 2025. Epley, a 30-year veteran of Caterpillar, currently serves as senior vice president of Global Finance Services.